1.Pharmacokinetics of Six Active Components in Shuganning Injection
Qing ZHANG ; Ningfang KANG ; Yang ZENG ; Feng HE ; Siying CHEN ; Yi CHEN ; Jianqing PENG ; Yueting LI ; Lin ZHENG ; Yong HUANG ; Yang JIN ; Zipeng GONG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(24):176-187
ObjectiveTo investigate the pharmacokinetics of six active components-scutellarin, baicalein, oroxylin A, geniposide, oroxylin A glucuronide, and baicalin-in Shuganning injection following single and multiple doses in rats, thus comparing the pharmacokinetics of Shuganning injection at different doses and under different dosing regimens. MethodsFirstly, ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was employed to establish a method for simultaneous determination of six active components-scutellarin, baicalein, oroxylin A, geniposide, oroxylin A glucuronide, and baicalinin—in rat plasma. Then, SD rats were assigned into a single-dose group and a multiple-dose group according to different dosing regimens. Each of the single-dose group and multiple-dose group were designed with low, medium, and high concentrations for tail vein injection. The rats were subjected to jugular vein cannulation, and blood samples were collected from the jugular vein at different time points before and after administration of Shuganning injection the next day, transferred into heparinized Eppendorf tubes, and centrifuged to separate plasma. Finally, the UPLC-MS/MS method was employed to determine the plasma concentrations of six active components at different time points. WinNonlin 8.2 software was used to analyze the pharmacokinetic parameters. ResultsA UPLC-MS/MS method was established for simultaneous determination of scutellarin, baicalein, oroxylin A, geniposide, oroxylin A glucuronide, and baicalinin in rat plasma and to study the pharmacokinetic characteristics at low, medium, and high concentrations after tail vein injection of Shuganning injection with single and multiple doses. The method verified that the linear relationship of each component in rat plasma samples was good (R2>0.995). The extraction recovery and matrix effect ranged from 92.12% to 112.48%. The intra-day and inter-day precision, accuracy, and stability met the requirements of biological sample analysis. For single-dose administration, the area under curve (AUC0-t) values of the six components increased with the increase in concentration, suggesting that the six components showed dose-dependent pharmacokinetic characteristics in vivo. For multiple-dose administration, compared with the single-dose group, at low concentrations, the AUC0-t and AUC0-∞ of baicalein increased, and the mean residence time (MRT0-∞) of the other five components except oroxylin A glucoronide prolonged. At medium concentrations, AUC0-t and AUC0-∞ increased, and clearance (CL) decreased. At high concentrations, the AUC0-t and AUC0-∞ of baicalein and geniposide increased, and the increase in AUC0-t may be due to the fact that the previous drug has not been completely eliminated at the next administration, resulting in a certain accumulation. It is hypothesized that the plasma concentration of Shuganning injection in SD rats may accumulate to a certain extent after seven consecutive days of administration once a day. ConclusionShuganning injection in different concentrations and different dosing regimens exhibit pharmacokinetic differences, which provides a theoretical basis for the clinical application of Shuganning Injection.
2.Cable-Pin System minimally invasive treatmentversus open reduction and Kirschner wire tension band technology for the repair of transverse patella fractures:a randomized controlled trial
Yongliang JIANG ; Chunwen LU ; Yungang WU ; Jinhui WU ; Muchen DING ; Runxiao LV ; Kai KANG ; Ningfang MAO
Chinese Journal of Tissue Engineering Research 2015;(26):4229-4234
BACKGROUND:Open reduction and Kirschner wire tension band technique has been a traditional surgical method for the treatment of patela fracture. However, there stil exist some complications such as Kirschner wire slippage and breakage. Cable-Pin system is a new fixation device. A series of good clinical results has been achieved in patients with patela fracture using this fixation device through a minimaly invasive way. OBJECTIVE:To compare and investigate the clinical results of minimaly invasive fixation with Cable-Pin system and Kirschner wire tension band technique for patela fracture and the complications. METHODS:Eighty patients with radiology-confirmed transverse displacement of patela participated in this trial, and were randomly divided into two groups. Forty patients underwent a minimaly invasive technique and the others had conventional open surgery using Kirschner wire. At postoperative intervals of 1, 3, 6, 12, and 24 months, pain was measured by Visual Analogue Scale scores, range of motion was measured by goniometry, and knee function was evaluated using the Bostman clinical grading scale. RESULTS AND CONCLUSION: Easement of pain was better in the minimaly invasive surgery group than in the control group at 1 and 3 months after treatment (P < 0.05). Above dominance disappeared at 6 months after treatment. At 3-24 months, the knee flexion training was faster and flexion angle was greater in the minimaly invasive surgery group, and results were significantly better than in the control group (P < 0.05). The incidence of discomfort fixation-induced complications was lower in the minimaly invasive surgery group than in the conventional open surgery group (P < 0.05). These data confirm that after minimaly invasive fixation with Cable-Pin system, pain was noticeably lessened, range of motion of affected knee was great, the recovery of knee function was better, the incidence of complications was reduced, and the repair effect was better than the conventional Kirschner wire fixation.
3.Analysis of serum homocysteine levels in patients with colorectal cancer
Yinglan ZHANG ; Hongmei SHI ; Ningfang FAN ; Yujiao FENG ; Yan KANG
Cancer Research and Clinic 2012;24(8):550-552
Objective To investigate the changes of serum homocysteine (Hcy) level before and after treatment in patients with colorectal cancer,and provide the reference for clinical therapeutic efficacy and prognosis.Methods Enzymatic circling assay was used to measure the serum Hcy levels in 50 controls and 58 patients with colorectal cancer before and after treatment with a.follow-up of 12 months.The changes of Hcy aud the relationship between Hcy and therapeutic efficacy or prognosis were analyzed.Results Scrum Hcy level in patients with colorectal cancer was significantly higher than that in controls [(16.90±5.35) μmol/L vs (10.23±3.06) μmol/L] (P < 0.01),and it was closely associated with TNM stage.Serum Hcy level in patients of stage Ⅲ-Ⅳ was significantly higher than that of stage Ⅰ-Ⅱ [(18.49±5.13) μmol/L vs (15.20±4.86) μmol/L] (P < 0.05).The Hcy level in patients at the end of treatment was significantly lower than that before treatment [(13.39±4.98) μmol/L vs (16.90±5.35) μmol/L] (P < 0.01),and the Hcy level after the treatment for 3 month was significantly lower than that at the end of treatment [(10.23±3.17) μmol/L] (P < 0.05).The Hcy level in patients with recurrence during 12 months after operation was significantly higher than that without recurrence [(17.18±4.82) μmol/L vs (12.36±3.19) μmol/L] (P < 0.01).Conclusion Serum level of Hcy might be a useful marker for predicting therapeutic efficacy and prognosis in patients with colorectal cancer.

Result Analysis
Print
Save
E-mail